Cost-effectiveness of dutasteride-tamsulosin combination therapy for the treatment of symptomatic benign prostatic hyperplasia: A Canadian model based on the CombAT trial

INTRODUCTION: Benign prostatic hyperplasia (BPH) is common in men 50 years old and older. The main treatment options are alpha-blockers (such as tamsulosin), which reduce symptoms, and 5-alpha reductase inhibitors (such as dutasteride), which reduce symptoms and slow disease progression. Clinical st...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Ismaila, Afisi, Walker, Anna, Sayani, Amyn, Laroche, Bruno, Nickel, J. Curtis, Posnett, John, Su, Zhen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Canadian Medical Association 2013
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3699085/
https://ncbi.nlm.nih.gov/pubmed/23826050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.12131
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg